Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

  • Franziska Duda
  • Susanne Bradel
  • André Bleich
  • Philipp Abendroth
  • Tanja Heemeier
  • Nina Ehlert
  • Peter Behrens
  • Karl Heinz Esser
  • Thomas Lenarz
  • Gudrun Brandes
  • Nils K. Prenzler

Organisationseinheiten

Externe Organisationen

  • Medizinische Hochschule Hannover (MHH)
  • Stiftung Tierärztliche Hochschule Hannover
  • Exzellenzcluster Hearing4all
Forschungs-netzwerk anzeigen

Details

OriginalspracheEnglisch
Seiten (von - bis)17-29
Seitenumfang13
FachzeitschriftJournal of Biomaterials Applications
Jahrgang30
Ausgabenummer1
PublikationsstatusVeröffentlicht - 6 Feb. 2015

Abstract

For several centuries silver is known for its antibacterial effects. The middle ear is an interesting new scope for silver application since chronic inflammations combined with bacterial infection cause complete destruction of the fragile ossicle chain and tympanic membrane. The resulting conductive deafness requires tympanoplasty for reconstruction. Strategies to prevent bacterial growth on middle ear prostheses are highly recommended. In this study, rabbits were implanted with Bioverit® II middle ear prostheses functionalized with silver containing dense and nanoporous silica films which were compared with pure silica coatings as well as silver sulfadiazine cream applied on nanoporous silica coating. The health status of animals was continuously monitored; blood was examined before and after implantation. After 21 days, the middle ears were inspected; implants and mucosal samples were processed for electron microscopy. Autopsies were performed and systemic spreading of silver was chemically analyzed exemplarily in liver and kidneys. For verification of direct cytotoxicity, NIH 3T3 cells were cultured on similar silver containing silica coatings on glass up to 3 days. In vitro a reduced viability of fibroblasts adhering directly on the samples was detected compared to cells growing on the surrounding plastic of the same culture dish. In transmission electron microscopy, phagocytosed silver silica fragments, silver sulfadiazine cream as well as silver nanoparticles were noticed inside endosomes. In vivo, clinical and post mortem examinations were inconspicuous. Chemical analyses showed no increased silver content compared to controls. Mucosal coverages on almost all prostheses were found. But reduction of granulation tissue was only obvious around silver-coated implants. Single necroses and apoptosis in the mucosa were correlated by intracellular accumulation of metallic silver. For confirming supportive healing effects of middle ear implants, silver ion aggregates need to be tested in the future to optimize biocompatibility while assuring bactericidal effects in the middle ear.

ASJC Scopus Sachgebiete

Zitieren

Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits. / Duda, Franziska; Bradel, Susanne; Bleich, André et al.
in: Journal of Biomaterials Applications, Jahrgang 30, Nr. 1, 06.02.2015, S. 17-29.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Duda, F, Bradel, S, Bleich, A, Abendroth, P, Heemeier, T, Ehlert, N, Behrens, P, Esser, KH, Lenarz, T, Brandes, G & Prenzler, NK 2015, 'Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits', Journal of Biomaterials Applications, Jg. 30, Nr. 1, S. 17-29. https://doi.org/10.1177/0885328215570103
Duda, F., Bradel, S., Bleich, A., Abendroth, P., Heemeier, T., Ehlert, N., Behrens, P., Esser, K. H., Lenarz, T., Brandes, G., & Prenzler, N. K. (2015). Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits. Journal of Biomaterials Applications, 30(1), 17-29. https://doi.org/10.1177/0885328215570103
Duda F, Bradel S, Bleich A, Abendroth P, Heemeier T, Ehlert N et al. Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits. Journal of Biomaterials Applications. 2015 Feb 6;30(1):17-29. doi: 10.1177/0885328215570103
Duda, Franziska ; Bradel, Susanne ; Bleich, André et al. / Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits. in: Journal of Biomaterials Applications. 2015 ; Jahrgang 30, Nr. 1. S. 17-29.
Download
@article{8a1cc0c4de5c4986bc4dcb96a74d6a81,
title = "Biocompatibility of silver containing silica films on Bioverit{\textregistered} II middle ear prostheses in rabbits",
abstract = "For several centuries silver is known for its antibacterial effects. The middle ear is an interesting new scope for silver application since chronic inflammations combined with bacterial infection cause complete destruction of the fragile ossicle chain and tympanic membrane. The resulting conductive deafness requires tympanoplasty for reconstruction. Strategies to prevent bacterial growth on middle ear prostheses are highly recommended. In this study, rabbits were implanted with Bioverit{\textregistered} II middle ear prostheses functionalized with silver containing dense and nanoporous silica films which were compared with pure silica coatings as well as silver sulfadiazine cream applied on nanoporous silica coating. The health status of animals was continuously monitored; blood was examined before and after implantation. After 21 days, the middle ears were inspected; implants and mucosal samples were processed for electron microscopy. Autopsies were performed and systemic spreading of silver was chemically analyzed exemplarily in liver and kidneys. For verification of direct cytotoxicity, NIH 3T3 cells were cultured on similar silver containing silica coatings on glass up to 3 days. In vitro a reduced viability of fibroblasts adhering directly on the samples was detected compared to cells growing on the surrounding plastic of the same culture dish. In transmission electron microscopy, phagocytosed silver silica fragments, silver sulfadiazine cream as well as silver nanoparticles were noticed inside endosomes. In vivo, clinical and post mortem examinations were inconspicuous. Chemical analyses showed no increased silver content compared to controls. Mucosal coverages on almost all prostheses were found. But reduction of granulation tissue was only obvious around silver-coated implants. Single necroses and apoptosis in the mucosa were correlated by intracellular accumulation of metallic silver. For confirming supportive healing effects of middle ear implants, silver ion aggregates need to be tested in the future to optimize biocompatibility while assuring bactericidal effects in the middle ear.",
keywords = "drug release system, electron microscopy, nanoporous silica, silver ions, Total ossicular chain reconstructive prosthesis",
author = "Franziska Duda and Susanne Bradel and Andr{\'e} Bleich and Philipp Abendroth and Tanja Heemeier and Nina Ehlert and Peter Behrens and Esser, {Karl Heinz} and Thomas Lenarz and Gudrun Brandes and Prenzler, {Nils K.}",
year = "2015",
month = feb,
day = "6",
doi = "10.1177/0885328215570103",
language = "English",
volume = "30",
pages = "17--29",
journal = "Journal of Biomaterials Applications",
issn = "0885-3282",
publisher = "SAGE Publications Ltd",
number = "1",

}

Download

TY - JOUR

T1 - Biocompatibility of silver containing silica films on Bioverit® II middle ear prostheses in rabbits

AU - Duda, Franziska

AU - Bradel, Susanne

AU - Bleich, André

AU - Abendroth, Philipp

AU - Heemeier, Tanja

AU - Ehlert, Nina

AU - Behrens, Peter

AU - Esser, Karl Heinz

AU - Lenarz, Thomas

AU - Brandes, Gudrun

AU - Prenzler, Nils K.

PY - 2015/2/6

Y1 - 2015/2/6

N2 - For several centuries silver is known for its antibacterial effects. The middle ear is an interesting new scope for silver application since chronic inflammations combined with bacterial infection cause complete destruction of the fragile ossicle chain and tympanic membrane. The resulting conductive deafness requires tympanoplasty for reconstruction. Strategies to prevent bacterial growth on middle ear prostheses are highly recommended. In this study, rabbits were implanted with Bioverit® II middle ear prostheses functionalized with silver containing dense and nanoporous silica films which were compared with pure silica coatings as well as silver sulfadiazine cream applied on nanoporous silica coating. The health status of animals was continuously monitored; blood was examined before and after implantation. After 21 days, the middle ears were inspected; implants and mucosal samples were processed for electron microscopy. Autopsies were performed and systemic spreading of silver was chemically analyzed exemplarily in liver and kidneys. For verification of direct cytotoxicity, NIH 3T3 cells were cultured on similar silver containing silica coatings on glass up to 3 days. In vitro a reduced viability of fibroblasts adhering directly on the samples was detected compared to cells growing on the surrounding plastic of the same culture dish. In transmission electron microscopy, phagocytosed silver silica fragments, silver sulfadiazine cream as well as silver nanoparticles were noticed inside endosomes. In vivo, clinical and post mortem examinations were inconspicuous. Chemical analyses showed no increased silver content compared to controls. Mucosal coverages on almost all prostheses were found. But reduction of granulation tissue was only obvious around silver-coated implants. Single necroses and apoptosis in the mucosa were correlated by intracellular accumulation of metallic silver. For confirming supportive healing effects of middle ear implants, silver ion aggregates need to be tested in the future to optimize biocompatibility while assuring bactericidal effects in the middle ear.

AB - For several centuries silver is known for its antibacterial effects. The middle ear is an interesting new scope for silver application since chronic inflammations combined with bacterial infection cause complete destruction of the fragile ossicle chain and tympanic membrane. The resulting conductive deafness requires tympanoplasty for reconstruction. Strategies to prevent bacterial growth on middle ear prostheses are highly recommended. In this study, rabbits were implanted with Bioverit® II middle ear prostheses functionalized with silver containing dense and nanoporous silica films which were compared with pure silica coatings as well as silver sulfadiazine cream applied on nanoporous silica coating. The health status of animals was continuously monitored; blood was examined before and after implantation. After 21 days, the middle ears were inspected; implants and mucosal samples were processed for electron microscopy. Autopsies were performed and systemic spreading of silver was chemically analyzed exemplarily in liver and kidneys. For verification of direct cytotoxicity, NIH 3T3 cells were cultured on similar silver containing silica coatings on glass up to 3 days. In vitro a reduced viability of fibroblasts adhering directly on the samples was detected compared to cells growing on the surrounding plastic of the same culture dish. In transmission electron microscopy, phagocytosed silver silica fragments, silver sulfadiazine cream as well as silver nanoparticles were noticed inside endosomes. In vivo, clinical and post mortem examinations were inconspicuous. Chemical analyses showed no increased silver content compared to controls. Mucosal coverages on almost all prostheses were found. But reduction of granulation tissue was only obvious around silver-coated implants. Single necroses and apoptosis in the mucosa were correlated by intracellular accumulation of metallic silver. For confirming supportive healing effects of middle ear implants, silver ion aggregates need to be tested in the future to optimize biocompatibility while assuring bactericidal effects in the middle ear.

KW - drug release system

KW - electron microscopy

KW - nanoporous silica

KW - silver ions

KW - Total ossicular chain reconstructive prosthesis

UR - http://www.scopus.com/inward/record.url?scp=84930858219&partnerID=8YFLogxK

U2 - 10.1177/0885328215570103

DO - 10.1177/0885328215570103

M3 - Article

C2 - 25659947

AN - SCOPUS:84930858219

VL - 30

SP - 17

EP - 29

JO - Journal of Biomaterials Applications

JF - Journal of Biomaterials Applications

SN - 0885-3282

IS - 1

ER -